Covestor’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3
Closed 2578
2024
Q2
$0 Hold
3
﹤0.01% 2589
2024
Q1
$0 Hold
3
﹤0.01% 2580
2023
Q4
$0 Hold
3
﹤0.01% 2527
2023
Q3
$0 Hold
3
﹤0.01% 2515
2023
Q2
$0 Hold
3
﹤0.01% 2479
2023
Q1
$0 Sell
3
-3
-50% -$262 ﹤0.01% 2401
2022
Q4
$1K Hold
6
﹤0.01% 1907
2022
Q3
$0 Hold
6
﹤0.01% 2394
2022
Q2
$1K Hold
6
﹤0.01% 1772
2022
Q1
$1K Buy
+6
New +$519 ﹤0.01% 1901

Other funds holding NVS

Covestor's NVS Position: Q3 2024 in Review

Covestor sold out of Novartis (NVS) in Q3 2024, closing a stake of 3 shares.

Covestor first reported a position in NVS in Q1 2022 and held it in 10 quarters. The position peaked at $1K in Q4 2022. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Covestor reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • Covestor sold 3 Novartis shares in Q3 2024.
  • Covestor first reported a position in Novartis in Q1 2022 and held it in 10 quarters.
  • Covestor's Novartis position peaked at $1K in Q4 2022.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Covestor's 13F filing for Q3 2024, filed 1 Nov 2024.